ASPN

Add to Watchlist

Advanced Chart

0.000

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

High

7.680

Open

7.430

VWAP

7.51

Vol

2.40M

Mkt Cap

624.53M

Low

7.180

Amount

18.00M

EV/EBITDA(TTM)

8.17

Total Shares

76.16M

592.66M

EV/OCF(TTM)

8.60

P/S(TTM)

1.41

Aspen Aerogels, Inc. is an aerogel technology company, which provides sustainability and electrification solutions. Its aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Its segments include Energy Industrial and Thermal Barrier. Under the Energy Industrial, it designs, develops and manufactures aerogel insulation used in the energy industrial and sustainable insulation markets. It offers two aerogel insulation product lines for the energy industrial market, Pyrogel and Cryogel. Under the Thermal Barrier, it offers PyroThin product, is an ultra-thin, lightweight and flexible thermal barrier designed with other functional layers to impede the propagation of thermal runaway across multiple lithium-ion battery system architectures. Its thermal barrier technology is designed to offer a combination of thermal management, mechanical performance and fire protection properties.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

72.53M

-38.42%

-0.123

-158.73%

68.33M

-41.77%

-0.077

-140.27%

72.45M

-41.14%

-0.050

-135.71%

Estimates Revision

The market is revising Downward the revenue expectations for Aspen Aerogels, Inc. (ASPN) for FY2025, with the revenue forecasts being adjusted by -23.37% over the past three months. During the same period, the stock price has changed by 36.94%.

Revenue Estimates for FY2025

Revise Downward

-23.37%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-266.67%

In Past 3 Month

Stock Price

Go Up

+36.94%

In Past 3 Month

6 Analyst Rating

11.84% Upside

Wall Street analysts forecast ASPN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPN is 8.50 USD with a low forecast of 7.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

2 Hold

0 Sell

Moderate Buy

11.84% Upside

Current: 7.600

Low

7.00

Averages

8.50

High

10.00

11.84% Upside

Current: 7.600

Low

7.00

Averages

8.50

High

10.00

Barclays

Overweight -> Equal Weight

downgrade

$13 -> $7

2025-05-29

Reason

Barclays

Price Target

$13 -> $7

2025-05-29

downgrade

Overweight -> Equal Weight

Reason

Barclays downgraded Aspen Aerogels to Equal Weight from Overweight with a price target of $7, down from $13. As the pace of electric vehicle production in the U.S. slows, Aspen is recalibrating its Thermal Barrier unit while Energy Industrial "remains the stalwart underpinning" its EBITDA, the analyst tells investors in a research note. The firm says that with Thermal Barrier growth "curtailed," it downgrades the shares "as upside seems diminished."

B. Riley

Buy

downgrade

$22 -> $10

2025-05-09

Reason

B. Riley

Price Target

$22 -> $10

2025-05-09

downgrade

Buy

Reason

B. Riley lowered the firm's price target on Aspen Aerogels to $10 from $22 and keeps a Buy rating on the shares following the Q1 report. The firm cut estimates, noting Aspen guided below expectations. The company is educing fixed costs, with a line of sight to meaningful growth in 2027, the analyst tells investors in a research note.

TD Cowen

Buy

downgrade

$11 -> $9

2025-05-09

Reason

TD Cowen

Price Target

$11 -> $9

2025-05-09

downgrade

Buy

Reason

TD Cowen lowered the firm's price target on Aspen Aerogels to $9 from $11 and keeps a Buy rating on the shares. Soft Q1 results and Q2 guidance turn "2025 into a transition year on further EV production weakness," the analyst tells investors. However, the firm's one to three year U.S. EV demand view is "still more constructive than consensus" and while it is reducing estimates it still likes the risk/reward post pullback, the analyst added.

Oppenheimer

Outperform -> Perform

downgrade

2025-05-08

Reason

Oppenheimer

Price Target

2025-05-08

downgrade

Outperform -> Perform

Reason

Oppenheimer downgraded Aspen Aerogels to Perform from Outperform.

Oppenheimer

Colin Rusch

Outperform -> Perform

downgrade

2025-05-08

Reason

Oppenheimer

Colin Rusch

Price Target

2025-05-08

downgrade

Outperform -> Perform

Reason

Oppenheimer analyst Colin Rusch downgraded Aspen Aerogels to Perform from Outperform and removed the firm's previous price target after the company missed Q1 estimates and guided below the Street. While the firm expects management to complete a covenant adjustment with MidCap Financial and continues to believe Aspen has "differentiated and defensible" intellectual property, it adds that demand fundamentals have "deteriorated more substantially then we anticipated."

Barclays

David Anderson

Buy

Maintains

$25 → $13

2025-02-19

Reason

Barclays

David Anderson

Price Target

$25 → $13

2025-02-19

Maintains

Buy

Reason

Barclays analyst J. David Anderson lowered the firm's price target on Aspen Aerogels to $13 from $25 and keeps an Overweight rating on the shares. The firm says that as a supplier of thermal barrier protection for electric vehicle batteries, the EV demand outlook has "meaningfully shifted" under President Trump, forcing Aspen to shift its expansion plans to a piecemeal approach relying on external manufacturing.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Aspen Aerogels Inc (ASPN.N) is -25.35, compared to its 5-year average forward P/E of 7.80. For a more detailed relative valuation and DCF analysis to assess Aspen Aerogels Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

7.80

Current PE

-25.35

Overvalued PE

62.55

Undervalued PE

-46.95

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-20.75

Current EV/EBITDA

27.55

Overvalued EV/EBITDA

26.81

Undervalued EV/EBITDA

-68.32

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

3.97

Current PS

2.17

Overvalued PS

6.87

Undervalued PS

1.08